XML 20 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Assets    
Cash and cash equivalents [1],[2] $ 40,348 $ 29,345
Cash and investments segregated and on deposit for regulatory purposes (including resale agreements of $14,904 and $9,028 at December 31, 2020 and 2019, respectively) [1] 50,399 20,483
Receivables from brokerage clients — net [1] 64,440 21,767
Available for sale securities [1] 337,400 61,422
Held to maturity securities [1] 0 134,706
Bank loans — net [1] 23,813 18,212
Equipment, office facilities, and property — net [1] 2,883 2,128
Goodwill [1] 11,952 1,227
Acquired intangible assets — net [1] 9,991 128
Other assets [1] 7,783 4,587
Total assets [1] 549,009 294,005
Liabilities and Stockholders’ Equity    
Bank deposits [1] 358,022 220,094
Payables to brokerage clients [1] 104,201 39,220
Accrued expenses and other liabilities [1] 17,094 5,516
Long-term debt [1] 13,632 7,430
Total liabilities [1] 492,949 272,260
Stockholders’ equity:    
Preferred stock — $.01 par value per share; aggregate liquidation preference of $7,850 and $2,850 at December 31, 2020 and 2019, respectively [1] 7,733 2,793
Common stock [1] 20 15
Additional paid-in capital [1] 26,515 4,656
Retained earnings [1] 21,975 19,960
Treasury stock, at cost — 193,577,648 and 201,818,100 shares at December 31, 2020 and 2019, respectively [1] (5,578) (5,767)
Accumulated other comprehensive income (loss) [1] 5,394 88
Total stockholders’ equity [1] 56,060 21,745
Total liabilities and stockholders’ equity [1] 549,009 294,005
Nonvoting Common Stock [Member]    
Stockholders’ equity:    
Common stock [1] 1 0
Total stockholders’ equity $ 1 $ 0
[1] Certain prior year amounts have been reclassified to conform to the current year presentation. See Note 1 for additional information.
[2] For more information on the nature of restrictions on restricted cash and cash equivalents, see Note 23.